Capital Expense Fund; FY2026 appropriation to MDA for future nuclear development.

2025 Regular Session Introduced by Joel Carter

SB 3239 would create the FY2026 Capital Expense Fund, with an appropriation to MDA to support future nuclear development, directing public funds toward long-term infrastructure.

Died In Committee

#appropriations

Summary of SB 3239 — Capital Expense Fund; FY2026 appropriation to MDA for future nuclear development

Overview

SB 3239 would create or designate a Capital Expense Fund appropriation for Fiscal Year 2026 to support future nuclear development activities by MDA (the designated agency in the bill). The bill advanced in its introduction but did not progress beyond the committee stage, as it died in committee.

Bill number: SB 3239

Title: Capital Expense Fund; FY2026 appropriation to MDA for future nuclear development

Status: Died In Committee

Introduced: February 26, 2025

Legislative actions:

2025-02-26 — Referred To Appropriations
2025-02-26 — Died In Committee

Purpose and intent

The core aim of SB 3239 is to provide FY2026 funding into a Capital Expense Fund designated for future nuclear development activities conducted by MDA.

By directing resources into a capital fund, the bill intends to support long-term investment in nuclear development infrastructure, planning, or related capital projects undertaken by the agency.

Key provisions (as indicated by title and summary)

Establishment or designation of a Capital Expense Fund for FY2026.

An appropriation to that fund allocated to MDA for the purpose of pursuing future nuclear development initiatives.

The bill would specify that the funds be used for capital expenditures tied to nuclear development as carried out by MDA.

Details such as eligible projects, match requirements, oversight, reporting, or sunset provisions are not specified in the provided information.

Fiscal and policy implications

Public funds would be directed to a capital reserve intended to support nuclear development efforts by MDA, signaling a focus on long-term infrastructure and project development rather than immediate operating expenses.

Without the text, there are no explicit dollar amounts, match requirements, or compliance measures available in the summary. If enacted, funding levels and accountability provisions would shape the fiscal impact and transparency.

Affected entities and stakeholders

Primary: MDA (recipient and implementing agency).

Potential downstream beneficiaries include contractors, suppliers, and communities involved in or affected by nuclear development projects.

The bill would likely involve oversight by appropriations committees and related state fiscal authorities.

Procedural history and timeline

Introduced: February 26, 2025.

Referred to: Appropriations on the same date.

Outcome: Died in committee on February 26, 2025, preventing advancement in that legislative session.

Potential next steps

If reintroduced in a future session, SB 3239 would again proceed through standard committee review, potential amendments, and floor consideration.

Any reintroduction would require sponsor support and alignment with the budget process and appropriations timelines.

Notes

The summary reflects the information available: title, status, and stated actions. Specific language, dollar figures, eligible uses, and oversight mechanisms are not provided in the available details.